Objective:Describe the epidemiological and paraclinical aspects of HP infection in hepatitis B virus carriers. PopulationandMethod:This was a descriptive cross-sectional study running from January 1 to August 30, 2019, a period of 8 months. It took place in the Hospital Centers of the two major cities of Congo (Brazzaville and Pointe-Noire). The target population of our study consists of patients carrying HBV under antiviral treatment or not. Patients aged at least 18 years and consenting with a biological and morphological assessment were included. We did not include in our study patients taking or having taken antibiotics and/or PPIs less than 4 weeks ago. We excluded all patients who did not deposit fresh stools and those in whom stool extraction could not be done manually. The variables studied covered sociodemographic, clinical and paraclinical aspects. Data entry was done using Excel 8.0 software. Statistical analysis was carried out with SPSS 20.0 software. Results:During our study, we included 169 patients. The frequency of HPAG in the stools of HBV carriers in our study population was 63.9% (n = 109). Male patients represented 69% (n = 75) and female patients represented 31% (n = 34). The average age of the patients is 43.92 ± 13.51 years with extremes of 18 years and 80 years. Concerning profession, unemployed patients and those working in the private sector were the most represented in respectively 28.4% (n = 31) and 22.9% (n = 25) without statistical link. Households comprising between 4 - 10 people and the use of public latrines were the risk factors most represented in respectively 69% (n = 75) and 88% (n = 96) without statistical link. Clinically, hepatomegaly and signs of portal hypertension were most represented in 53% (n = 58) and 47% (n = 51). Biologically, HBV DNA was detectable in 60.5% of cases (n = 66).
References
[1]
World Health Organisation (2019) Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. World Health Organisation Guidelines. 10-12.
[2]
James, K.Y., Hooi, Wan, Y.L., etal. (2017) Global Prevalence of Helicobacterpylori Infection: Systematic Review and Meta-Analysis. Gastroenterology, 153, 420-429. https://doi.org/10.1053/j.gastro.2017.04.022
[3]
World Health Organization (2017) Weekly Epidemiological Record. WER, 27, 369-392.
[4]
Kramvis, A. and Kew, M.C. (2007) Epidemiology of Hepatitis B Virus in Africa, Its Genotypes and Clinical Associations of Genotypes. HepatologyResearch, 37, 9-19. https://doi.org/10.1111/j.1872-034X.2007.00098.x
[5]
Atipo-Ibara, B.I., Itoua-Ngaporo, N.A., Dzia-Lepfoundzou, A., etal. (2015) Virus de l’hépatite B au Congo (Brazzaville): Séroprévalence et diversité génétique chez les donneurs de sang en zones hyper endémiques. AfricanJournalofGastroenterologyandHepatology, 9, 127-131. https://doi.org/10.1007/s12157-015-0607-7
[6]
Itoua-Ngaporo, N.A., Mimiesse Monamou, J.F., Ahoui Apendi, C., etal. (2018) Epidemiological, Clinical and Endoscopic Profile of Helicobacterpylori Infection in Two Digestive Endoscopy Centers in Brazzaville. Gastroenterology, Hepatology&DigestiveDisorders, 1, 1-5. https://doi.org/10.33425/2639-9334.1025
[7]
Roche, B., Samuel, D., Pawlotsky, J.M., Dhumeaux, D., etal. (2009) Histoire naturelle de l’infection par le virus de l’hépatite B. Hépatite B. 2 éd. SèvresCedex (France), 6, 95-111. https://doi.org/10.1051/978-2-84254-223-8.c009
[8]
Abu Al-Soud, W., Sterram, U., Ljungh, A., etal. (2008) DNA of Helicobacter spp and Common Gut Bacteria in Primary Liver Carcinoma. DigestiveandLiverDisease, 40, 126-131. https://doi.org/10.1016/j.dld.2007.09.011
[9]
Amal, A.M., Amal, A.E., etal. (2018) Association between Severity of Liver Disease, Frequency of Hélicobacterpylori Infection, and Degree of Gastric Lesion in Egyptian Patients with Hepatitis B Virus Infection. AmericanJournalofTropicalMedicineandHygiene, 98, 221-226. https://doi.org/10.4269/ajtmh.17-0291
[10]
Wang, D.Z., Chen, W., Yang, S., etal. (2015) Helicobacterpylori Infection in Chinese Patients with Atrial Fibrillation. ClinicalInterventionsinAging, 10, 813-819. https://doi.org/10.2147/CIA.S72724
[11]
Ponzetto, A., Pellicano, R., Leone, N., etal. (2000) Helicobacterpylori Seroprevalence in Cirrhotic Patients with Hepatitis B Virus Infection. TheNetherlandsJournalofMedicine, 56, 206-210. https://doi.org/10.1016/S0300-2977(00)00033-4
[12]
Hao, H.Q. (2015) The Research of HBV Related Liver Disease and Helicobacterpylori Infection. PublicMedicalForumMagazine, 19, 2921-2922.
[13]
Li, B.S. (2011) The Association between Helicobacterpylori Infection and HBV DNA Loads in Patients with Chronic Hepatitis B. ChinaPracticeMedicine, 10, 2-3.
[14]
Ministère du Plan, de l’Aménagement, du Territoire, de l’Intégration Economique et du NEPAD, Centre National de la Statistique et des Etudes Economiques (2012) Enquête Démographique et de Santé du Congo (EDSC-II).
[15]
Séhonou, J., Kpossou, A.R., Kanvi, J.P., etal. (2019) Helicobacterpylori Infection in Hepatitis B Virus Carriers in Cotonou: Epidemiology and Sociodemographic Factors Associated with the Coinfection. Gastroenterology&Hepatology: OpenAccess, 10, 14-17. https://doi.org/10.15406/ghoa.2019.10.00350
[16]
Wang, M.Y., Yue, J.Y., Zhang, Y.X., etal. (2011) Helicobacterpylori Infection in Asymptomatic HBV Carriers, Alcohol Users and Normal Adult Population in Shandong Province, China. ClinicsandResearchinHepatologyandGastroenterology, 3, 560-562. https://doi.org/10.1016/j.clinre.2010.12.014
[17]
Ji, S.W., Wang, J.B. and Zhang, Y.G. (2008) The Helicobacterpylori Infection in Patients with Chronic Hepatitis B and the Relative Factor Analysis. Liver, 20, 5-7. https://doi.org/10.11569/wcjd.v16.i5.535
[18]
Xi, J.D. (2015) The Helicobacterpylori Infection in Patients with Chronic Hepatitis B, and/or Cirrhosis, Hepatocellular Carcinoma. HebeiMedicine, 21, 42-45.